• Explore /
  • Poster
  • / Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Preliminary results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) for the non-L sarcoma cohort.

Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Preliminary results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) for the non-L sarcoma cohort.

Abstract Poster

Authors

Daniel Pink

Daniel Pink

Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie, Transplantationszentrum, Palliativmedizin, Universität Greifswald and Klinik für Hämatologie, Onkologie und Palliativmedizin-Sarkomzentrum, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany

Daniel Pink , Dimosthenis Andreou , Anne Flörcken , Alexander Golf , Stephan Richter , Torsten Kessler , Martin Kortüm , Christian Andreas Schmidt , Bernd Kasper , Eva Wardelmann , Jeanette Bahr , Daniel Wilhelm Mueller , Disorn Sookthai , Salah-Eddin Al-Batran , Peter Reichardt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03590210

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 11545)

DOI

10.1200/JCO.2021.39.15_suppl.11545

Abstract #

11545

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Panpan Zhang

First Author: Manish R. Patel

First Author: Arndt Vogel

First Author: Erlinda Maria Gordon